AirSculpt Technologies, Inc.
NASDAQ:AIRSMedical - Care Facilities
+$0.21 today
- Market cap
- $53.08M
- Beta
- 2.34
- P/E (TTM)
- -31.1
- EPS (TTM)
- -$0.16
Volume 0.49M
Average 1.46M
AIRS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AirSculpt Technologies, Inc.NASDAQ: AIRS
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AIRS compares with its peers on the latest reported figures
- AIRS's LTM Mar 2026 research & development of $0 is the 8th highest of the 11 companies compared; the peer median is $16.57M.
- Research & development amounts to 0.0% of revenue for AIRS, versus a peer median of 7.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $220.82M | +62.1% | +69.0% | — | |
| LTM Mar 2026 | $110.07M | -12.0% | +22.1% | — | |
| LTM Mar 2026 | $87.86M | -27.1% | -20.4% | 54.9% | |
| LTM Mar 2026 | $61.4M | -16.9% | +5.2% | 7.4% | |
| LTM Mar 2026 | $17.11M | +2.1% | +8.6% | 8.3% | |
| LTM Mar 2026 | $16.04M | -18.6% | -0.6% | 31.9% | |
| LTM Mar 2026 | $12.07M | -44.2% | -11.1% | 56.9% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AIRS) | $16.57M | -16.9% | +5.2% | 7.9% | |
Competitors are the stored peer set for AIRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 133.32M | 168.79M | 195.92M | 180.35M | 151.82M |
| Cost of Revenue | 44.54M | 58.28M | 74.01M | 71.38M | 61.69M |
| Gross Profit | 88.78M | 110.51M | 121.91M | 108.97M | 90.13M |
| Gross Margin | 66.6% | 65.5% | 62.2% | 60.4% | 59.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 65.73M | 105.92M | 108.28M | 105.58M | 82.18M |
| Operating Expenses | 73.01M | 115.06M | 112.42M | 110.78M | 94.96M |
| Depreciation & Amortization | 6.6M | 8.06M | 10.25M | 11.89M | 12.78M |
| EBITDA | 22.37M | 4.6M | 19.74M | 10.07M | 1.22M |
| EBITDA Margin | 16.8% | 2.7% | 10.1% | 5.6% | 0.8% |
| Operating Income | 15.77M | (4.55M) | 9.48M | (1.82M) | (4.83M) |
| Operating Margin | 11.8% | -2.7% | 4.8% | -1.0% | -3.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.89M | 6.75M | 6.49M | 6.25M | 6.08M |
| Other Income / Expenses | (4.89M) | (6.75M) | (6.49M) | (6.25M) | (12.81M) |
| Income Before Tax | 10.88M | (11.3M) | 3M | (8.06M) | (17.64M) |
| Pre-Tax Margin | 8.2% | -6.7% | 1.5% | -4.5% | -11.6% |
| Income Tax Expense | 329K | 3.38M | 7.48M | 188K | (5.97M) |
| Net Income | 10.55M | (14.68M) | (4.48M) | (8.25M) | (11.67M) |
| Net Margin | 7.9% | -8.7% | -2.3% | -4.6% | -7.7% |
| EPS (Basic) | (0.01) | (0.26) | (0.08) | (0.14) | (0.19) |
| EPS (Diluted) | (0.01) | (0.26) | (0.08) | (0.14) | (0.19) |
| Weighted Avg Shares | 55.64M | 55.68M | 56.78M | 57.69M | 60.45M |
| Weighted Avg Shares (Diluted) | 55.64M | 55.68M | 56.78M | 57.69M | 60.45M |
AirSculpt Technologies, Inc.
NASDAQ:AIRS
Intrinsic Alpha fair value
Locked
Current Price
$0.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.